US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 106.180
  • -2.670-2.45%
Close Apr 25 16:00 ET
  • 106.220
  • +0.040+0.04%
Pre 05:28 ET
40.65BMarket Cap-8611P/E (TTM)

About Moderna Company

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Technology Square
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-714-6500

Company Executives

  • Name
  • Position
  • Salary
  • Stephane Bancel
  • Director and Chief Executive Officer
  • 17.07M
  • Jerh Collins
  • Chief Technical Operations and Quality Officer
  • --
  • Shannon Thyme Klinger
  • Chief Legal Officer and Corporate Secretary
  • 4.31M
  • Kate Cronin
  • Chief Brand Officer
  • --
  • Tracey Franklin
  • Chief Human Resources Officer
  • --
  • Brad Miller
  • Chief Information Officer
  • --
  • James M Mock
  • Chief Financial Officer and Principal Accounting Officer
  • 4.32M
  • Dr. Noubar B. Afeyan, PhD
  • Chairman of the Board
  • 663.52K
  • Dr. Stephen Hoge, M.D.
  • President
  • 7.34M
  • Dr. Francois Nader, M.D.
  • Independent Director
  • 481.27K
  • Elizabeth E. Tallett
  • Independent Director
  • 481.27K
  • Stephen Berenson
  • Independent Director
  • 471.25K
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 481.27K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 476.25K
  • Paul Sagan
  • Independent Director
  • 461.27K
  • Dr. Robert S. Langer, Sc.D.
  • Independent Director
  • 461.27K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg